Systemic lupus erythematosus (SLE) is a complex autoimmune disease with multiorgan
manifestations, including pleuropulmonary involvement (20–90%). The precise mechanism …

Systemic lupus erythematosus (SLE) is an autoimmune rheumatic disease characterized by
the production of pathogenic autoantibodies and immune complexes and is responsible for …

Pulmonary Hypertension (PH) is a common manifestation in patients with Systemic Lupus
Erythematosus (SLE) and varies from asymptomatic to life-threatening disease. PH can …

Pulmonary arterial hypertension (PAH) is commonly associated with connective tissue
diseases (CTDs) including systemic sclerosis and systemic lupus erythematosus (SLE). The …

Systemic lupus erythematosus (SLE) is a systemic inflammatory disease, characterized
serologically by an autoantibody response to nucleic antigens, and clinically by injury and/or …

Objective Pulmonary arterial hypertension (PAH) is a severe complication of connective
tissue diseases (CTDs). This study aimed to investigate the clinical and hemodynamic …

Objectives To estimate the prevalence of pulmonary arterial hypertension (PAH) and risk
factors for PAH in patients registered in the Chinese SLE Treatment and Research group …

Objectives Primary Sjögren's syndrome (pSS) is an important cause of pulmonary arterial
hypertension (PAH), which remains insufficiently studied and needs attention. This study …

Systemic lupus erythematosus (SLE) is characterized by the second highest prevalence of
pulmonary arterial hypertension (PAH), after systemic sclerosis, among the connective …

Abstract Peking Union Medical College Hospital (PUMCH) has started a single-center right
heart catheterization (RHC)-based pulmonary arterial hypertension (PAH) study in systemic …